TONIX Pharmaceuticals’ Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology | Business Wire

Links shared publicly online about this topic.

  • 15
    total visits

TONIX Pharmaceuticals’ Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology | Business Wire

businesswire.com —

TONIX Pharmaceuticals, Inc. a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system (“CN

View full resource at businesswire.com

Tags: Nervous System, Disease and Condition, Pharma, Muscle Relaxer, Flexeril, Rheumatology

  • Share

Most Recently Shared on September 7, 2011 at 2:13 pm By:

Fibromyalgia_OW Fibromyalgia OW

TONIX Pharmaceuticals’ Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology: NEW YORK... http://t.co/PW6ONYl

9 months ago...

Reply

Retweet

Favorite

Advertisement